Capillary Tech. Q1 FY27 Earnings Call — Analysis (NSE: CAPILLARY)

Capillary Technologies delivered 43% YoY revenue growth to ₹256 Cr in Q1FY27 and expanded ARR past ₹1,000 Cr, while integrating SessionM at a net acquisition cost of ₹17 Cr and maintaining full-year beat expectations.

· Analysis by Alpha Inflection

Result quality: poor — Slipped to loss. Management sentiment: optimistic.

The take

Q1FY27 Revenue ₹256 Cr ( +43% YoY ) . New guidance — FY27 fy27 consolidated revenue and e… ₹1,065 Cr revenue and ₹172 Cr EBITDA . New story: M&A as CAC Substitution and Margin Arbitrage .

Results

Revenue reached ₹256 Cr (+43% YoY, 17% organic), EBITDA grew 132% YoY to ₹44 Cr (17.2% margin), while reported PAT stood at -₹9.55 Cr due to a one-time subsidiary cyber-banking fraud loss (normalized PAT ₹25 Cr).

Financial highlights

Capillary Tech. Q1 FY27 reported figures
MetricValueChangeBasis
Revenue₹256 Cr+43%yoy · Q1FY27
Organic Revenue Growth17%+17%yoy · Q1FY27 · excluding inorganic acquisitions and 6% FX tailwind
EBITDA₹44 Cr+132%yoy · Q1FY27
EBITDA Margin17.19%+619bpsyoy · Q1FY27 · improved from ~11% in Q1FY26
Reported PAT-₹9.55 Crnone · Q1FY27 · impacted by exceptional cyber fraud loss and deferred tax liability
Normalized PAT₹25 Cr+31.58%sequential · Q1FY27 · vs ₹19 Cr in Q4FY26
ARR₹1,026 Cr+33.99%point_in_time · Q1FY27 · Jun-26; up from ₹765 Cr in FY26
TTM New ACV₹92 Cr+75%yoy · Q1FY27 · excluding one large healthcare customer baseline in prior year
Net Acquisition Cost - SessionM₹17 Crpoint_in_time · Q1FY27 · net of debt/balance sheet adjustments from $20M headline EV

Guidance

Management reaffirmed expectations to beat FY27 guidance of ₹1,065 Cr in revenue and ₹172 Cr in EBITDA, targeting ~17% full-year organic revenue growth (~23% including FX).

What management committed to

Key themes

M&A margin turnaround and AI adoption

How the narrative shifted

Operational commentary

Analyst Q&A

Research and educational content only. Not investment advice.